Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | SHR-A2102 |
| Trade Name | |
| Synonyms | SHRA2102|SHR A2102|Notiretatug Rezetecan |
| Drug Descriptions |
SHR-A2102 is an antibody-drug conjugate (ADC) targeting Nectin-4, which potentially inhibits tumor growth (J Clin Oncol 2026 44: 16_Suppl, 4191). |
| DrugClasses | NECTIN4 Antibody 15 |
| CAS Registry Number | NA |
| NCIT ID | C200198 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| HRS-4642 + SHR-A2102 | HRS-4642 SHR-A2102 | 0 | 0 |
| SHR-A2102 | SHR-A2102 | 0 | 0 |